Summary
Perioperative myocardial protection constitutes one of the major advances of modern cardiac surgery, but perioperative assessment of its quality is difficult in clinical practice. This review details our approach to myocardial protection in specific situations, as well as the techniques we use to assess it in three different settings:
-
· Is distribution of antegrade cardioplegia homogeneous in patients presenting coronary artery stenosis? The problem was to determine if cardioplegic solutions used antegradely or retrogradely could represent a reliable echographic contrast for myocardial imaging in coronary artery disease patients and normal coronary artery patients, and further if significant differences of myocardial contrast exist between the two methods.
-
· Does warm reperfusion cardioplegia improve postoperative myocardial function in patients with an ejection fraction (EF) < 35%? Pre- and postoperative hemodynamic workup with construction of Starling curves were used to answer this question.
-
· Does reperfusion of ischemic hearts induce free radical formation in humans? Deleterious effects of reperfusion are usually determined by studying the effects of free radicals on the myocardium, by determining the concentrations of substances that reflect the degree of membrane phospholipid destruction. However, the specificity and the sensitivity of such assays are low. We recently described white cell chromosomal aberrations secondary to free radical formation, after ischemic and reperfusion injury. Values obtained are expressed as the percentage of the total number of chromosomes. Although specialized laboratory techniques are required, this test is higly accurate.
Similar content being viewed by others
References
Tyers G, Williams E, Hughes H, et al. Effects of perfusate temperature on myocardial protection from ischemia. J Thorac Cardiovasc Surg 1977;73:766–771.
Mihaileanu S, Fabiani JN, Julien J, et al. Comparative study between antegrade cardioplegia and retrograde cardioplegia using intraoperative myocardial contrast echography. In: Mohl W, Faxon D, Wolner E, eds. Clinics of coronary sinus infusion. Steinkopff Verlag Darmstatdt 1986:285.
Mac Cord J. Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med 1985;312:159–163.
Buckberg GD. Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage. J Thorac Cardiovasc Surg 1987;93:127–139.
Perier P, Fabiani JN, Bocher M. Etude hemodynamique des effets de l'allopurinol dans une solution cardioplegique. Arch Mal Coeur 1980;73:713.
Emerit I, Carutti P. Tumor promoter phorbol-myristate-acetate induces a clastogenic factor in human lymphocytes. Proc Natl Acad Sci USA 1982;79:7509.
Emerit I, Khan SH, Cerutti P. Treatment of lymphocyte cultures with a hypoxanthine-xanthine oxydase system induces the formation of transferable clastogenic material. J Free Radicals Biol Med 1985;1:51.
Emerit I, Fabiani JN, Ponzio O et al. Clastogenic factor in ischemia-reperfusion injury. Protective effect of allopurinol. Ann Thorac Surg 1988;46:619–624.
Shiki K, Masuda M, Yonenaga K et al. Myocardial distribution of retrograde flow through the coronary sinus of the excised normal canine heart. Ann Thorac Surg 1986; 41(3):265–271.
Fabiani J-N, Swanson J, Deloche A, Carpentier A. Right atrial cardioplegia. In: Roberts A., ed. Myocardial protection in cardiac surgery. New York: Marcel Dekker 1987: 505–514.
Carpentier A. Cardiac valve surgery: The French correction. J Thorac Cardiovasc Surg 1983;86:323–337.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fabiani, JN., Jebara, V. & Carpentier, A. Perioperative assessment of the quality of myocardial protection. Cardiovasc Drug Ther 4 (Suppl 4), 797–803 (1990). https://doi.org/10.1007/BF00051277
Issue Date:
DOI: https://doi.org/10.1007/BF00051277